Why is the US targeting Germany's drug industry?

In the world according to Donald Trump, every nation on the face of the earth is “ripping off” the United States — that goes for pharmaceuticals, too, especially those from Germany. Now, the Trump administration is targeting Germany with an investigation. Washington says it wants to find out if US patients and businesses are being forced to pay disproportionately higher prices for the research and development of top-tier pharmaceuticals so that German patients can pay less. The inquiry, scheduled to wrap up in September, is based on Section 301 of the Trade Act of 1974 and could ultimately lead to […]... Keep on reading: Why is the US targeting Germany's drug industry?